Mark Fitzgerald

Active 1979–2025

Also published as
Mark FitzGerald
133
Papers
21,937
Citations
69
h-index
121
i10-index

Citations

Citations per year for Mark Fitzgerald1965: 1 citations1980: 1 citations1981: 1 citations1982: 1 citations1985: 6 citations1986: 1 citations1987: 5 citations1989: 3 citations1990: 3 citations1991: 9 citations1993: 7 citations1994: 7 citations1995: 6 citations1996: 18 citations1997: 29 citations1998: 27 citations1999: 41 citations2000: 58 citations2001: 61 citations2002: 86 citations2003: 94 citations2004: 99 citations2005: 132 citations2006: 105 citations2007: 143 citations2008: 144 citations2009: 184 citations2010: 186 citations2011: 176 citations2012: 212 citations2013: 187 citations2014: 179 citations2015: 156 citations2016: 116 citations2017: 135 citations2018: 107 citations2019: 400 citations2020: 480 citations2021: 716 citations2022: 589 citations2023: 374 citations2024: 574 citations2025: 235 citations2026: 16 citations1966–1979: no citations, so these years are not shown1983–1984: no citations, so these years are not shown1988: no citations, so this year is not shown1992: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,575 citing papers, 24.2% of this breakdownUnited Kingdom: 979 citing papers, 9.2% of this breakdownCanada: 635 citing papers, 6% of this breakdownChina: 618 citing papers, 5.8% of this breakdownGermany: 535 citing papers, 5% of this breakdownAustralia: 467 citing papers, 4.4% of this breakdownNetherlands: 435 citing papers, 4.1% of this breakdownItaly: 417 citing papers, 3.9% of this breakdownFrance: 322 citing papers, 3% of this breakdownSpain: 240 citing papers, 2.3% of this breakdownSwitzerland: 231 citing papers, 2.2% of this breakdownSweden: 194 citing papers, 1.8% of this breakdown
0%24.2%Other 28.1%

Fields

  • Medicine62%
  • Neuroscience17.4%
  • Psychology4.7%
  • Biochemistry, Genetics and Molecular Biology3.7%
  • Immunology and Microbiology3%
  • Dentistry1.8%
  • Other7.4%

Topics

  • Asthma and respiratory diseases4.6%
  • COVID-19 Clinical Research Studies3.6%
  • Neural and Behavioral Psychology Studies3.3%
  • Functional Brain Connectivity Studies3.1%
  • Chronic Obstructive Pulmonary Disease (COPD) Research2.6%
  • Trauma and Emergency Care Studies2.5%
  • Other80.3%

Coauthors

All papers

Open in search
  1. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michelle A. Detry, Christina Saunders, Mark Fitzgerald, Nicholas Berry, Lazaro Mwandigha, Ushma Galal, Sam Mort, Bhautesh Jani, Nigel Hart, Haroon Ahmed, Daniel Butler, Micheal McKenna, Jem Chalk, Layla Lavallee, Elizabeth Hadley, Lucy Cureton, Magdalena Benysek, Monique Andersson, Maria Coates, Sarah Barrett, Clare Bateman, Jennifer Davies, Ivy Raymundo-Wood, Andrew Ustianowski, Andrew Carson‐Stevens, Ly‐Mee Yu, Paul Little, Akosua Adom Agyeman, Tanveer Ahmed, Damien Allcock, Adrian Beltran-Martinez, Oluseye E Benedict, Nigel C. Bird, Laura K. Brennan, Julianne R. Brown, Gerard P. Burns, Mike Butler, Zelda Cheng, Ruth Danson, Nigel de Kare-Silver, Devesh Dhasmana, Jon M Dickson, Serge Engamba, Stacey Fisher, Robin Fox, Eve Frost, Richard A. Gaunt, Sarit K. Ghosh, Ishtiaq A Gilkar, Anna L. Goodman, Steve Granier, Aleksandra Howell, Iqbal Hussain, Simon M. Hutchinson, Marie Imlach, Greg Irving, Nicholas Jacobsen, James Kennard, Umar Khan, Kyle Knox, Christopher Krasucki, Tom Law, Rem Lee, Nicola Lester, David Lewis, J.A. Lunn, Claire I. Mackintosh, Mehul Mathukia, Patrick S. Moore, Seb Morton and 35 more - The Lancet 2022 cited by 406

  2. Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 402

  3. Decision Curve Analysis

    Authors: , , - JAMA 2015 cited by 877

  4. Global strategy for asthma management and prevention: GINA executive summary

    Authors: , , , , , , , , , , , , , - European Respiratory Journal 2007 cited by 3,234

  5. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth Lorenzi, John Marshall, Daniel F. McAuley, Anna McGlothin, Shay McGuinness, Bryan J. McVerry, Stephanie A. Montgomery, Paul Mouncey, Srinivas Murthy, Alistair Nichol, Rachael Parke, Rachael Parke, Kathy Rowan, Ashish Sanil, Marlene Santos, Christina Saunders, Christopher Seymour, Anne Turner, Frank L. van de Veerdonk, Balasubramanian Venkatesh, Ryan Zarychanski, Scott Berry, Roger Lewis, Colin McArthur, Steven A. Webb, Anthony Gordon - JAMA 2020 cited by 884

  6. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Εleftherios Ζervas, Enrico Heffler, Flavia Hoyte, Francesca Puggioni, George Christoff, Giorgio Walter Canonica, Giovanna Elisiana Carpagnano, Giuseppe Guida, Gregory Katsoulotos, Guy Brusselle, Hitashi Rupani, Hubertus Jersmann, I. Clifton, Jaideep Dhariwal, James Fingleton, Jane Duke, Janet Rimmer, John Aubrey Douglass, João Fonseca, Job F. M. van Boven, John Corless, John Harrington, Jorge Máspero, José Luís San Miguel, Kanok Pipatvech, Karrinda Kenny, Kenneth R. Chapman, Κonstantinos Κostikas, Lauri Lehtimäki, Li Ping Chung, Liam G. Heaney, Liang‐Wen Hang, Louis‐Philippe Boulet, Luis Pérez de Llano, L Ricciardi, Majdy Idrees, Manlio Milanese, Maria Elisabetta Conte, Maria Teresa Costantino, Mariko Koh Siyue, Mark Fitzgerald, Mark Hew, Matthew Peters, Ming‐Ju Tsai, Mitesh Patel, Mohammad Hashim Khan, Mohsen Sadatsafavi, Mona Al‐Ahmad, Mona‐Rita Yacoub, Mónica De Gennaro, Naghmeh Radhakrishna, Nicola A. Hanania, Nikolaos G. Papadopoulos, Njira Lugogo, Norma Linaker, Nunzio Crimi, Paddy Dennison, Parameswaran Nair, Patrick Mitchell, Paul M. O’Byrne, Paul Pfeffer, Paula Kauppi, Pauline Hughes, Peter G. Middleton, Peter Wark, Philip G. Bardin, Pin‐Kuei Fu, Praveen Akuthota, Rekha Chaudhuri, R. Diaz Campos and 18 more - The Journal of Allergy and Clinical Immunology In Practice 2021 cited by 145

  7. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth Lorenzi, Scott Berry, Lindsay R. Berry, Aaron W. Aday, Farah Al-Beidh, Djillali Annane, Yaseen M. Arabi, Diptesh Aryal, Bihari, Shailesh, Abi Beane, Zahra Bhimani, Shailesh Bihari, Henny H. Billett, Lindsay Bond, Marc J. M. Bonten, Frank Brunkhorst, Meredith Buxton, Adrian Buzgau, Lana A. Castellucci, Sweta Chekuri, Jen‐Ting Chen, Allen Cheng, Tamta Chkhikvadze, Benjamin Coiffard, Todd W. Costantini, Sophie de Brouwer, Lennie Derde, Michelle A. Detry, Abhijit Duggal, Vladimír Džavík, Mark B. Effron, Lise J Estcourt, Brendan M. Everett, Dean Fergusson, Mark Fitzgerald, Robert Fowler, J.‐P. Galanaud, Benjamin Galen, Sheetal Gandotra, Sebastián García‐Madrona, Timothy D. Girard, Lucas C. Godoy, Andrew L. Goodman, Herman Goossens, Cameron Green, Yonatan Greenstein, Peter L Gross, Naomi M. Hamburg, Rashan Haniffa, George P. Hanna, Nicholas Hanna, Sheila M. Hegde, Carolyn M. Hendrickson, R. Duncan Hite, Alexander Hindenburg, Aluko A. Hope, James M Horowitz, Christopher M. Horvat, Kristin Hudock, Beverley J. Hunt, Mansoor Husain, Robert C. Hyzy, Vivek Iyer, Jeffrey R. Jacobson, Devachandran Jayakumar, Norma Keller, Akram Khan, Yuri Kim, Andrei Kindzelski, Andrew J. King and 78 more - 2021 cited by 589

  8. 2018 UK national guideline for the management of infection with Neisseria gonorrhoeae

    Authors: , , , , - International Journal of STD & AIDS 2019 cited by 258

  9. Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Baumann Kreuziger, Abi Beane, Jeffrey S. Berger, Scott Berry, Lindsay R. Berry, Zahra Bhimani, Shailesh Bihari, Henny H. Billett, Lindsay Bond, Marc J. M. Bonten, Charlotte Bradbury, Maria M. Brooks, Frank Brunkhorst, Meredith Buxton, Adrian Buzgau, Marc Carrier, Lana A. Castelucci, Sweta Chekuri, Jen‐Ting Chen, Allen Cheng, Tamta Chkhikvadze, Benjamin Coiffard, Aira Contreras, Todd W. Costantini, Mary Cushman, Sophie de Brouwer, Lennie Derde, Michelle A. Detry, Abhijit Duggal, Vladimír Džavík, Mark B. Effron, Heather Eng, Jorge Escobedo, Lise J Estcourt, Brendan M. Everett, Micheal E. Farkough, Dean Fergusson, Mark Fitzgerald, Rob Fowler, Joshua D. Froess, Zhuxuan Fu, J.‐P. Galanaud, Benjamin Galen, Sheetal Gandotra, Timothy D. Girard, Lucus D. Godoy, Ewan C. Goligher, Michelle N. Gong, Andrew L. Goodman, Herman Goossens, Anthony Gordon, Cameron Green, Yonatan Greenstein, Peter L. Gross, Raquel Morillo Guerrero, Naomi M. Hamburg, Rashan Haniffa, George P. Hanna, Nicholas Hanna, Sheila M. Hedge, Carolyn M. Hendrickson, Alisa M. Higgins, Alexander Hindenburg, R. Duncan Hite, Judith S. Hochman, Aluko A. Hope, James M Horowitz, Christopher M. Horvat, Brett L. Houston, David T. Huang and 111 more - JAMA 2023 cited by 98

  10. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2021 cited by 318

  11. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Benjamin R. Saville, Oghenekome Gbinigie, Oliver van Hecke, Emma Ogburn, Philip Evans, Nicholas Thomas, Mahendra Patel, Duncan Richards, Nicholas Berry, Michelle A. Detry, Christina Saunders, Mark Fitzgerald, Victoria Harris, Milensu Shanyinde, Simon de Lusignan, Monique Andersson, Peter J. Barnes, Richard EK Russell, Dan V. Nicolau, Sanjay Ramakrishnan, Richard Hobbs, Christopher Butler, Richard Hobbs, Richard Hobbs, Christopher Butler, Christopher Butler - The Lancet 2021 cited by 310

  12. Improved Assessment of Significant Activation in Functional Magnetic Resonance Imaging (fMRI): Use of a Cluster‐Size Threshold

    Authors: , , , , , - Magnetic Resonance in Medicine 1995 cited by 3,234

  13. Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the Need for Longitudinal Observational Studies in COPD

    Authors: , , , , , , , , , , , , , , , - COPD Journal of Chronic Obstructive Pulmonary Disease 2012 cited by 192

  14. Hypocalcemia in trauma patients: A systematic review

    Authors: , , , , , , - The Journal of Trauma: Injury, The Journal of Trauma: Injury, Infection, and Critical Care 2020 cited by 114

  15. Prospective Randomized Controlled Trial of Operative Rib Fixation in Traumatic Flail Chest

    Authors: , , , , , , , , - Journal of the American College of Surgeons 2013 cited by 467

  16. Long-term health status and trajectories of seriously injured patients: A population-based longitudinal study

    Authors: , , , , , , , , , , , , - PLoS Medicine 2017 cited by 203

  17. Pre‐hospital freeze‐dried plasma for critical bleeding after trauma: A pilot randomized controlled trial

    Authors: , , , , , , , , , , , , - Academic Emergency Medicine 2023 cited by 29

  18. UK national guidelines on the management of syphilis 2015

    Authors: , , , , , , , , , , , , , , , , , , , - International Journal of STD & AIDS 2015 cited by 271

  19. Trauma-induced disturbances in ionized calcium levels correlate parabolically with coagulopathy, transfusion, and mortality: a multicentre cohort analysis from the TraumaRegister DGU®

    Authors: , , , , , - Critical Care 2023 cited by 53

  20. Prehospital Rapid Sequence Intubation Improves Functional Outcome for Patients With Severe Traumatic Brain Injury

    Authors: , , , , , , , , , , , , , , , , , - Annals of Surgery 2010 cited by 354

  21. National and regional asthma programmes in Europe

    Authors: , , , , , , , , , , , , , , , , , , - European Respiratory Review 2015 cited by 141

  22. Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Infection 2024 cited by 28

  23. Return to Work and Functional Outcomes After Major Trauma

    Authors: , , , , , , , , , - Annals of Surgery 2016 cited by 210

  24. Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2021 cited by 84